These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25306346)

  • 1. Resveratrol entrapped niosomes as yoghurt additive.
    Pando D; Beltrán M; Gerone I; Matos M; Pazos C
    Food Chem; 2015 Mar; 170():281-7. PubMed ID: 25306346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation of resveratrol entrapped niosomes for topical use.
    Pando D; Matos M; Gutiérrez G; Pazos C
    Colloids Surf B Biointerfaces; 2015 Apr; 128():398-404. PubMed ID: 25766923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol proniosomes as a convenient nanoingredient for functional food.
    Schlich M; Lai F; Pireddu R; Pini E; Ailuno G; Fadda AM; Valenti D; Sinico C
    Food Chem; 2020 Apr; 310():125950. PubMed ID: 31830712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, manufacture and characterization of niosomes for the delivery for nevirapine.
    Witika BA; Walker RB
    Pharmazie; 2019 Feb; 74(2):91-96. PubMed ID: 30782257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Tocopherol-loaded niosome prepared by heating method and its release behavior.
    Basiri L; Rajabzadeh G; Bostan A
    Food Chem; 2017 Apr; 221():620-628. PubMed ID: 27979250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of formulation compositions on niosomal preparations.
    Chaw CS; Kim KY
    Pharm Dev Technol; 2013; 18(3):667-72. PubMed ID: 22468904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of formulation variables and excipient interaction on the production of niosomes.
    Sezgin-Bayindir Z; Yuksel N
    AAPS PharmSciTech; 2012 Sep; 13(3):826-35. PubMed ID: 22644706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan.
    Ahad A; Raish M; Al-Jenoobi FI; Al-Mohizea AM
    Curr Drug Deliv; 2018 Feb; 15(2):260-266. PubMed ID: 28521674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol.
    Devaraj GN; Parakh SR; Devraj R; Apte SS; Rao BR; Rambhau D
    J Colloid Interface Sci; 2002 Jul; 251(2):360-5. PubMed ID: 16290741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Hydration Parameters and Co-Surfactants on Methylene Blue-Loaded Niosomes Prepared by the Thin Film Hydration Method.
    Yeo LK; Chaw CS; Elkordy AA
    Pharmaceuticals (Basel); 2019 Mar; 12(2):. PubMed ID: 30934834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanodesign of olein vesicles for the topical delivery of the antioxidant resveratrol.
    Pando D; Caddeo C; Manconi M; Fadda AM; Pazos C
    J Pharm Pharmacol; 2013 Aug; 65(8):1158-67. PubMed ID: 23837583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of drug molecular weight on niosomes size and encapsulation efficiency.
    García-Manrique P; Machado ND; Fernández MA; Blanco-López MC; Matos M; Gutiérrez G
    Colloids Surf B Biointerfaces; 2020 Feb; 186():110711. PubMed ID: 31864114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and characterization of ofloxacin niosomes.
    Ramalingam N; Natesan G; Dhandayuthapani B; Perumal P; Balasundaram J; Natesan S
    Pak J Pharm Sci; 2013 Nov; 26(6):1089-96. PubMed ID: 24191311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An electron spin resonance study of non-ionic surfactant vesicles (niosomes).
    Yeom S; Shin BS; Han S
    Chem Phys Lipids; 2014 Jul; 181():83-9. PubMed ID: 24721595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying the Taguchi method to optimize sumatriptan succinate niosomes as drug carriers for skin delivery.
    González-Rodríguez ML; Mouram I; Cózar-Bernal MJ; Villasmil S; Rabasco AM
    J Pharm Sci; 2012 Oct; 101(10):3845-63. PubMed ID: 22806266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery.
    Bayindir ZS; Yuksel N
    J Pharm Sci; 2010 Apr; 99(4):2049-60. PubMed ID: 19780133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alkyl glucopyranoside-based niosomes containing methotrexate for pharmaceutical applications: evaluation of physico-chemical and biological properties.
    Muzzalupo R; Tavano L; La Mesa C
    Int J Pharm; 2013 Dec; 458(1):224-9. PubMed ID: 24060370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Niosome-based hydrogel of resveratrol for topical applications: An effective therapy for pain related disorder(s).
    Negi P; Aggarwal M; Sharma G; Rathore C; Sharma G; Singh B; Katare OP
    Biomed Pharmacother; 2017 Apr; 88():480-487. PubMed ID: 28126673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved oral delivery of resveratrol using proliposomal formulation: investigation of various factors contributing to prolonged absorption of unmetabolized resveratrol.
    Basavaraj S; Betageri GV
    Expert Opin Drug Deliv; 2014 Apr; 11(4):493-503. PubMed ID: 24456117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elaboration and Physicochemical Characterization of Niosome-Based Nioplexes for Gene Delivery Purposes.
    Ojeda E; Agirre M; Villate-Beitia I; Mashal M; Puras G; Zarate J; Pedraz JL
    Methods Mol Biol; 2016; 1445():63-75. PubMed ID: 27436313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.